Polar Asset Management Partners Inc. Pliant Therapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 170,200 shares of PLRX stock, worth $2.19 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
170,200
Previous 46,600
265.24%
Holding current value
$2.19 Million
Previous $500,000
281.4%
% of portfolio
0.06%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
165Shares Held
63.1MCall Options Held
275KPut Options Held
159K-
Deep Track Capital, LP Greenwich, CT5.97MShares$76.7 Million2.47% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$63.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.83MShares$62.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$45.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$41.1 Million2.34% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $626M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...